11.02.2015 Views

barcelona . spain - European Association for the Study of the Liver

barcelona . spain - European Association for the Study of the Liver

barcelona . spain - European Association for the Study of the Liver

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BARCELONA . SPAIN<br />

54 POSTGRADUATE COURSE SYLLABUS ALCOHOLIC LIVER DISEASE 55<br />

APRIL 18 - 19/2012 THE INTERNATIONAL LIVER CONGRESS TM 2012<br />

HISTOPATHOLOGICAL ASSESMENT OF ALCOHOLIC LIVER DISEASE<br />

Tania Roskams<br />

Leuven, Belgium<br />

E-mail: tania.roskams@uz.kuleuven.ac.be<br />

KEY POINTS<br />

• Know <strong>the</strong> typical features <strong>of</strong> alcoholic liver disease (ALD) and <strong>the</strong> differences with o<strong>the</strong>r<br />

common etiologies <strong>of</strong> liver disease.<br />

• Understand <strong>the</strong> histopathological features which are most important in <strong>the</strong> prognostic<br />

assessment <strong>of</strong> ALD, in particular to make <strong>the</strong> differential diagnosis <strong>of</strong> so-called acute-onchronic<br />

liver disease and chronic decompensated liver disease.<br />

INTRODUCTION<br />

In <strong>the</strong> setting <strong>of</strong> alcoholic steatohepatitis (ASH), <strong>the</strong> clinician takes a liver biopsy to know 1) <strong>the</strong> etiology<br />

<strong>of</strong> <strong>the</strong> disease 2) eventual additional factors, 3) <strong>the</strong> stage <strong>of</strong> <strong>the</strong> disease, 4) <strong>the</strong> activity <strong>of</strong> <strong>the</strong> disease, 5)<br />

in case <strong>of</strong> sudden deterioration in <strong>the</strong> end stage <strong>the</strong> clinician wants to know if this is decompensation <strong>of</strong><br />

end-stage cirrhosis or so-called acute-on-chronic liver disease. These different aspects will be discussed<br />

during this talk.<br />

When receiving a needle biopsy <strong>of</strong> <strong>the</strong> liver <strong>the</strong> first feature a pathologist assesses is <strong>the</strong> architecture. A<br />

special fibrous tissue stain is necessary: e.g. sirius red or Masson’s trichrome. In alcoholic or non-alcoholic<br />

steatohepatitis, a fine threadery perisinusoidal, pericellular type <strong>of</strong> fibrosis is seen, resulting in <strong>the</strong><br />

typical chicken wire fibrosis. This type <strong>of</strong> fibrosis is caused by direct activation <strong>of</strong> stellate cells, which are<br />

located in <strong>the</strong> immediate vicinity <strong>of</strong> hepatocytes. Since alcohol is metabolized in <strong>the</strong> centrolobular area, <strong>the</strong><br />

fibrosis starts in this area, followed by periportal fine threadery fibrosis. Centrolobular fibrosis can affect <strong>the</strong><br />

draining centrolobular veins and cause outflow block at microscopical level. Paraportal shunt vessels and<br />

dilated sinusoids are signs <strong>of</strong> portal hypertension.<br />

The fine threadery perisinusoidal and pericellular type <strong>of</strong> fibrosis differs from biliary fibrosis, which is <strong>the</strong><br />

result <strong>of</strong> ductular reaction associated with activation <strong>of</strong> periductular fibroblasts resulting in porto-portal<br />

septa. The fine threadery fibrosis in NASH also differs from <strong>the</strong> type <strong>of</strong> fibrosis in viral or auto-immune<br />

hepatitis which is <strong>the</strong> results <strong>of</strong> interface hepatitis or confluent necrosis following <strong>the</strong> blood stream from<br />

which inflammatory cells diapede: from portal tracts to central veins: that’s why in hepatitis portal-central<br />

septa are seen, which is not <strong>the</strong> case in biliary type <strong>of</strong> fibrosis.<br />

The next structures to be examined are <strong>the</strong> portal tracts. In ASH little inflammation is seen compared to<br />

viral or auto-immune hepatitis and <strong>the</strong> infiltrate which is present is mainly composed <strong>of</strong> polymorphonuclear<br />

leucocytes. Portal phlebosclerosis is commonly seen, especially in more advanced stages <strong>of</strong> <strong>the</strong><br />

disease. At <strong>the</strong> interface with <strong>the</strong> parenchyma ductular reaction is <strong>of</strong>ten seen as a sign <strong>of</strong> regeneration,<br />

because alcohol inhibits <strong>the</strong> regenerative capacity <strong>of</strong> <strong>the</strong> hepatocytes, hence activating <strong>the</strong> progenitor<br />

cell compartment (Roskams et al 2003). It can also be <strong>the</strong> results <strong>of</strong> secondary sclerosing cholangitis<br />

which is also quite common in <strong>the</strong> more advanced stages <strong>of</strong> disease, ei<strong>the</strong>r secondary to <strong>the</strong> liver<br />

fibrosis or secondary to sclerosing pancreatitis. Features are similar to primary sclerosing cholangitis:<br />

thickened basement membranes, ductular reaction and cholangiolitis, but ductopenia is lacking. A special<br />

histopathological features is ductular bilirubinostasis: ductules at <strong>the</strong> interface <strong>of</strong> <strong>the</strong> portal tracts with<br />

<strong>the</strong> surrounding parenchyma are dilated and contain bilirubin plugs. This is an early sign <strong>of</strong> infection be<strong>for</strong>e<br />

clinical signs are obvious.<br />

The parenchyma in (N)ASH shows steatosis: microvesicular, mediovesicular and finally macrovesicular.<br />

In alcoholic disease, <strong>the</strong> steatosis is localized in <strong>the</strong> centrolobular area since alcohol is metabolized<br />

<strong>the</strong>re, while in (N)ASH steatosis is distributed more randomly and associated with glycogenated nuclei.<br />

Ballooning <strong>of</strong> hepatocytes and <strong>for</strong>mation <strong>of</strong> Mallory-Denk bodies (MDB) are also typical <strong>for</strong> ASH. MDB<br />

surrounded by polymorphs are called satellitosis and are a sign <strong>of</strong> active alcohol use. To objectivate<br />

MDB an immunohistochemical stain <strong>for</strong> ubiquitin can be used. Also <strong>the</strong> presence <strong>of</strong> satellitosis is better<br />

objectivated using this stain. Megamitochondria are a sign <strong>of</strong> active metabolization <strong>of</strong> alcohol. Hepatocytic<br />

bilirubinostasis is a sign <strong>of</strong> decompensation <strong>of</strong> <strong>the</strong> hepatocyte function.<br />

Acute on chronic liver failure<br />

In <strong>the</strong> context <strong>of</strong> chronic liver insufficiency, <strong>the</strong> term “acute-on-chronic liver failure” (ACLF) was introduced<br />

about a decade ago in an attempt to demarcate a syndrome with a similar clinical context and onset, but<br />

with heterogeneity in etiology <strong>of</strong> underlying liver disease and rapidity <strong>of</strong> clinical presentation (Jalan 2002 and<br />

Laleman 2006). Although ACLF, in its first (only) working definition, was described as an acute deterioration<br />

in liver function in a patient with previously well-compensated liver disease due to <strong>the</strong> effects <strong>of</strong> a precipitating<br />

event, yet this entity remains poorly defined. Clinically, this syndrome is characterized by jaundice, hepatic<br />

encephalopathy, hemodynamic instability and/or hepatorenal syndrome, and leads to a mortality <strong>of</strong> 50 to<br />

90% because <strong>of</strong> <strong>the</strong> combined impact <strong>of</strong> <strong>the</strong>se manifestations The importance <strong>of</strong> this syndrome resides<br />

in <strong>the</strong> conceptual suggestion <strong>of</strong> reversibility or recompensation since if <strong>the</strong> patient can tide over <strong>the</strong> acute<br />

episode <strong>of</strong> liver failure and associated subsequent multi-organ dysfunction; he could re-emerge above <strong>the</strong><br />

critical threshold <strong>of</strong> functional liver cell mass and as such preclude <strong>the</strong> need <strong>for</strong> transplantation (Jalan 2002,<br />

Sen 2002 and Laleman 2006). In this way, ACLF has to be distinguished from chronic relentless hepatic<br />

decompensation (CHD), which usually occurs in patients with end-stage cirrhosis as a result <strong>of</strong> progression<br />

<strong>of</strong> <strong>the</strong>ir underlying liver disease. Because this is deemed irreversible due to loss <strong>of</strong> regeneration potential,<br />

liver transplantation is <strong>the</strong> only <strong>the</strong>rapeutic option. Accordingly <strong>the</strong> key elements in ACLF compared to<br />

<strong>the</strong> CHD state are <strong>the</strong> ability to recompensate (reversibility) and <strong>the</strong> presence <strong>of</strong> a precipitating hit, which<br />

initiates a cascade <strong>of</strong> devastating events. Whe<strong>the</strong>r this reversibility is related to regeneration potential has<br />

not been investigated yet. There<strong>for</strong>e in a previous study (Katoonizadeh et al 2010) we aimed to address<br />

this question. In addition, we investigated <strong>the</strong> importance <strong>of</strong> early clinical characteristics, <strong>the</strong> identification<br />

and relative role <strong>of</strong> precipitating factors and a wide spectrum <strong>of</strong> histological parameters (Table). Upon<br />

histological pro<strong>of</strong> <strong>of</strong> cirrhosis and use <strong>of</strong> <strong>the</strong> clinical working definition, we were able to characterize two<br />

different groups <strong>of</strong> patients in our homogenous population <strong>of</strong> patients with alcoholic cirrhosis. In an<br />

attempt to elucidate <strong>the</strong> different outcome despite relatively similar clinical presentation, we reviewed <strong>the</strong><br />

two essential elements characterizing ACLF, namely regeneration potential and <strong>the</strong> influence <strong>of</strong> precipitating<br />

events. Regenerative ability was studied in <strong>the</strong> 2 groups by evaluating <strong>the</strong> degree <strong>of</strong> activation <strong>of</strong> HPCs and<br />

hepatocytes replication. Our results showed that HPCs were equally highly activated in both groups, while<br />

<strong>the</strong> number <strong>of</strong> proliferating hepatocytes was comparably low. Accordingly, difference in regenerative ability<br />

seems – at least histologically – not to explain <strong>the</strong> disparity in survival and challenges <strong>the</strong> quintessence <strong>of</strong><br />

“regenerative potential” in <strong>the</strong> definition <strong>of</strong> ACLF. Although we admit to certain shortcomings related to <strong>the</strong><br />

manner <strong>of</strong> assessment, at present histological assessment, however, remains by far <strong>the</strong> most ‘simple’, most<br />

clinically accessible and direct index <strong>of</strong> regenerative potential.<br />

If we next consider <strong>the</strong> effect <strong>of</strong> a potential precipitating event, we documented a key role <strong>for</strong> an apparently<br />

triggered and dysregulated inflammatory response. Our investigations revealed that in patients<br />

with ACLF features <strong>of</strong> infection such as SIRS and ductular bilirubinostasis at biopsy were early<br />

characteristics <strong>of</strong> ACLF.<br />

Increased susceptibility to infections in patients with (alcoholic) cirrhosis has already previously been reported<br />

and is now generally accepted (Wong 2005). In clinical practice, however, <strong>the</strong> problem is <strong>the</strong> lack <strong>of</strong> a highlysensitive,<br />

cheap, easily and rapidly available detection assays <strong>for</strong> detection <strong>of</strong> infection. In this setting,<br />

positive SIRS criteria, used and validated already earlier in septic shock and multi-organ failure (Muckart<br />

1997), might represent an alternative approach and early additive tool. In our study, we clearly showed that

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!